DelveInsight’s Atherectomy Devices Market Insights Report 2034 provides the current and forecast market analysis, individual leading Atherectomy Devices companies’ market shares, challenges, Atherectomy Devices Market Drivers, barriers, trends, and key market Atherectomy Devices companies in the market.
To read more about the latest highlights related to the Atherectomy Devices Market @ https://www.delveinsight.com/report-store/atherectomy-devices-market
Key Takeaways from the Atherectomy Devices Market Report
- In January 2025, AngioDynamics, Inc. initiated a new clinical trial to expand the indications of its Auryon Atherectomy System to treat below-the-knee peripheral artery disease. Strategic significance: Broadens the addressable patient population for a leading laser atherectomy platform.
- In November 2024, Koninklijke Philips N.V. announced enrollment of the first US patient in a clinical trial for a combined laser atherectomy and intravascular lithotripsy catheter. Strategic significance: Advances a dual-function platform designed to simplify peripheral artery disease treatment by combining multiple therapeutic modalities into a single procedure.
- In September 2024, AngioDynamics Inc. received European CE Mark approval for its Auryon Atherectomy System, enabling commercialization in Europe for peripheral artery disease, including critical limb ischemia and in-stent restenosis. Strategic significance: Expands the company’s addressable market and regulatory footprint outside the United States.
- The Atherectomy Devices market is estimated at USD 1.12 billion in 2025 and is projected to reach USD 2.34 billion by 2034. Growth is anchored in the rising global burden of coronary and peripheral artery disease, the accelerating shift toward minimally invasive revascularization, and continuous innovation in directional, rotational, orbital, and laser plaque-modification technology.
- The global Atherectomy Devices market is growing at a CAGR of 8.5% during the forecast period from 2026 to 2034.
- The principal drivers are the rising global burden of coronary and peripheral artery disease; growing preference for minimally invasive revascularization; technological advancements in device design and imaging integration; accelerating regulatory approvals and label expansions; expansion of outpatient and ambulatory interventional care; and strategic M&A and investment activity.
- The leading Atherectomy Devices Companies include Koninklijke Philips N.V., Medtronic PLC, Boston Scientific Corporation, AngioDynamics Inc., Abbott Laboratories, Avinger, BD, Ra Medical Systems, REX Medical, and Cardio Flow, Inc., among others.
To know more about why North America is leading the market growth in the Atherectomy Devices Market, Get a snapshot @ https://www.delveinsight.com/report-store/atherectomy-devices-market
Atherectomy Devices Overview
Atherectomy is a catheter-based, minimally invasive procedure that mechanically removes atherosclerotic plaque, calcium, and thrombus from diseased coronary and peripheral arteries to restore luminal patency without relying solely on balloon dilation or permanent stent placement. Atherectomy devices are purpose-built to cut, shave, sand, or photo-ablate plaque, and are engineered as directional, rotational, orbital, or laser (photo-ablative) systems, each suited to distinct lesion morphologies. Because coronary artery disease, peripheral artery disease, and in-stent restenosis frequently involve heavily calcified or fibrotic lesions that resist conventional angioplasty, interventional cardiologists and vascular specialists increasingly turn to atherectomy as a vessel-preparation and standalone debulking tool.
Atherectomy Devices Market Key Growth Drivers
- The rising global burden of cardiovascular disease is driving demand, with an estimated 200 million people worldwide affected by coronary heart disease as of 2024, alongside millions more living with peripheral artery disease and stroke.
- The growing prevalence of peripheral artery disease, particularly among aging, diabetic, and hypertensive populations, is expanding demand for effective, durable plaque-removal solutions.
- Increasing preference for minimally invasive procedures over open surgical revascularization is accelerating adoption, given shorter hospital stays, faster recovery, and reduced complication rates.
- Continuous technological advancement, including image-guided atherectomy, intravascular ultrasound and OCT integration, and combination laser/lithotripsy platforms, is improving procedural precision and safety.
- Accelerating regulatory approvals and label expansions, including AngioDynamics’ September 2024 CE Mark for the Auryon Atherectomy System, are widening addressable indications.
- Expansion of outpatient and ambulatory surgical center-based interventional cardiology is broadening access and lowering the cost of atherectomy procedures.
- Strategic consolidation, including Abbott’s acquisition of Cardiovascular Systems, Inc., underscores the strategic value of atherectomy technology and is expected to sustain innovation investment through 2034.
Get a sneak peek at the Atherectomy Devices Market Dynamics @ https://www.delveinsight.com/report-store/atherectomy-devices-market
Atherectomy Devices Market Segment Analysis
The Atherectomy Devices Market by Product (Directional, Rotational, Orbital, and Laser Atherectomy Devices), Application (Coronary Artery Disease, Peripheral Artery Disease, In-Stent Restenosis), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of World).
By product, directional atherectomy devices led the market with roughly 40% share in 2025, given their exceptional versatility and precision across both peripheral and coronary lesions, though laser atherectomy devices are projected to register the fastest growth. By application, peripheral artery disease led with roughly 50% share in 2025, reflecting atherectomy’s role as a first-line debulking strategy for femoropopliteal and below-the-knee lesions, particularly heavily calcified plaque. By end-user, hospitals led with roughly 65% share in 2025, given the advanced catheterization laboratories, intravascular imaging systems, and multidisciplinary teams that complex atherectomy procedures require. North America led global revenue with roughly 42% share in 2025, the largest of any region, while Asia-Pacific is the fastest-growing region, driven by a large aging population and rapid healthcare infrastructure development.
Which MedTech key players in the Atherectomy Devices Market are set to emerge as the trendsetter explore @ https://www.delveinsight.com/report-store/atherectomy-devices-market
Atherectomy Devices Market Competitive Landscape
The Atherectomy Devices market is classified as Highly Consolidated. A small group of major players, including Medtronic, Boston Scientific, and Abbott, dominate the market through extensive R&D capabilities, broad product portfolios, and global distribution networks, while specialized innovators such as AngioDynamics, Avinger, Ra Medical Systems, REX Medical, and Cardio Flow compete through focused technology platforms and expanding regulatory clearances.
Atherectomy Devices Companies
Koninklijke Philips N.V., Medtronic PLC, Boston Scientific Corporation, AngioDynamics Inc., Abbott Laboratories, Avinger, BD, Ra Medical Systems, REX Medical, Cardio Flow, Inc., and others.
Atherectomy Devices Market Restraints
Despite strong momentum, the Atherectomy Devices market faces material constraints. The high cost of atherectomy systems and associated procedures limits adoption in price-sensitive markets and budget-constrained healthcare settings. The risk of procedural complications, including vessel perforation, dissection, and post-procedure restenosis, tempers physician adoption in certain patient populations. The market also faces strong competition from established, lower-cost alternatives such as balloon angioplasty, stenting, and drug-coated balloons, which benefit from extensive long-term clinical data. A limited pool of interventional cardiologists and vascular surgeons trained in atherectomy techniques constrains adoption, particularly in developing regions, while fragmented and evolving regulatory frameworks across geographies add complexity for manufacturers seeking multi-market approval.
Interested in knowing the Atherectomy Devices Market by 2034? Click to get a snapshot of the Atherectomy Devices Market Trends- https://www.delveinsight.com/report-store/atherectomy-devices-market
Scope of the Atherectomy Devices Market Report
- Coverage- Global
- Forecast Period- 2026-2034
- Atherectomy Devices Companies- Koninklijke Philips N.V., Medtronic PLC, Boston Scientific Corporation, AngioDynamics Inc., Abbott Laboratories, Avinger, BD, Ra Medical Systems, REX Medical, Cardio Flow, Inc., and others.
- Atherectomy Devices Market Restraints and Regulatory Analysis
- Atherectomy Devices Porter Five Forces Analysis and Market Assessment
Explore more information of the Atherectomy Devices Market Insights @ https://www.delveinsight.com/report-store/atherectomy-devices-market
Table of Contents
- Atherectomy Devices Market Report Introduction
- Atherectomy Devices Market Executive Summary
- Atherectomy Devices Market Key Factors Analysis
- Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
- Regulatory Analysis
- Atherectomy Devices Market Porter’s Five Forces Analysis
- Atherectomy Devices Market Assessment
- Atherectomy Devices Market Competitive Landscape
- Atherectomy Devices Market Startup Funding and Investment Trends
- Atherectomy Devices Market Company and Product Profiles
- KOL Views
- Project Approach
- About DelveInsight
- Disclaimer and Contact Us
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Kanishk
